Stockscreener 앱 받기
14.07
1.37%
0.19
시간 외 거래:
14.20
0.13
+0.92%
Summit Therapeutics Inc 주식(SMMT)의 최신 뉴스
Why is SMMT stock tumbling today? - MSN
Summit Therapeutics: Getting A Foot In The Door Isn't Getting Through It (NASDAQ:SMMT) - Seeking Alpha
Summit Therapeutics Inc. (SMMT) Investor Outlook: Evaluating A Potential 103.85% Upside - DirectorsTalk Interviews
SMMT Jumps As Summit Therapeutics Rides Ivonescimab Momentum - timothysykes.com
Summit rebounds after nearly $50M insider purchase - MSN
Summit Therapeutics (SMMT) Raises $500 Million Through Public Offering - Insider Monkey
Insider Buying: Summit Therapeutics Co-CEO, President & Director Bought US$1.5m Of Shares - simplywall.st
Summit Therapeutics files for $500M common stock offering; shares slide over 9% - MSN
Summit Therapeutics (SMMT) Shares Rebound After Co-CEO's $50M St - GuruFocus
5 Best Buy-the-Dip Stocks to Invest In Now - Insider Monkey
SMMT Jumps As Ivonescimab Trial Success Fuels Financing Drive - StocksToTrade
Summit Therapeutics (NASDAQ: SMMT) investors approve directors and 8M-share incentive plan boost - Stock Titan
Summit Therapeutics co-CEO Zanganeh acquires $49.98m in shares By Investing.com - Investing.com Australia
Summit Therapeutics(SMMT.US) 10% Shareholder Buys US$49.99 Million in Common Stock - Moomoo
Insider Stock Purchases: June 12, 2026 - Quiver Quantitative
Summit Therapeutics co-CEO Zanganeh acquires $49.98m in shares - Investing.com
Co-CEO Mahkam Zanganeh (SMMT) reports spouse’s 3.81M-share open-market buy - Stock Titan
Summit Therapeutics (SMMT) Shares Rebound After Co-CEO's $50M Stock Purchase - GuruFocus
Summit gains after nearly $50M insider buy (SMMT:NASDAQ) - Seeking Alpha
Summit Therapeutics stock rises after CEO share purchase By Investing.com - Investing.com Canada
Summit Therapeutics stock rises after CEO share purchase - Investing.com
Summit Therapeutics Insider Bought Shares Worth $49,987,200, According to a Recent SEC Filing - Moomoo
Summit Therapeutics co-CEO Robert Duggan buys $49.9m in stock - Investing.com India
Summit Therapeutics co-CEO Robert Duggan acquires 3.81 million shares - StreetInsider
Summit Therapeutics Co-Chief Executive Officer Purchased Shares Worth Over $49M - TradingView
Summit Therapeutics (SMMT) Co-CEO Robert Duggan buys 3.81M shares in open market - Stock Titan
Summit Therapeutics Halts US$500m Offering After Ivonescimab Trial Results - Yahoo Finance
Summit Therapeutics (SMMT) Withdraws Public Offering Amid Market Conditions - GuruFocus
Summit Therapeutics (SMMT) Withdraws $500M Public Offering Amid Market Conditions - GuruFocus
Summit pulls $500M share sale a day after announcing it - BioPharma Dive
Summit Therapeutics withdraws proposed securities offering citing market conditions - MSN
Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing - TradingView
Summit Therapeutics withdraws proposed underwritten offering citing market conditions - TradingView
Summit Therapeutics (NASDAQ: SMMT) pulls planned stock sale amid markets - Stock Titan
Summit Therapeutics stock hits 52-week low at 13.14 USD By Investing.com - Investing.com Nigeria
Summit Therapeutics (SMMT) Sees a 10.2% Decline - GuruFocus
Oil Jumps On Iran Strikes, Nasdaq 100 Falls On Hot Inflation: Stock Market Today - Benzinga
Summit Therapeutics stock hits 52-week low at 13.14 USD - Investing.com
2.60%
0.94%
자본화:
|
볼륨(24시간):